Form D Explorer

Inspect source fieldsReport a record issue

Form D — Protego Biopharma, Inc.

0001231919-25-000568 · filed Dec 3, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other Health Care filings

Offering

Industry
Other Health Care
Exemptions
Rule 506(b)
Reported offering amount
$130,442,180
Reported amount sold
$32,942,190
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Protego Biopharma, Inc.
CIK
1796909
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
10945 VISTA SORRENTO PARKWAY, SUITE 150
SAN DIEGO, California 92130
Phone
(858) 355-9290

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗